ArticleCancer immunology, immunotherapy : CII2013

The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer.

Hideya Onishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.